Skelaxin

Category:

Description

Drug Description

Skelaxin is a miorelaxant with generic name Metaxalone. It looks like an odorless white crystalline powder, easily soluble in chloroform, but insoluble in water. Each pill of Skelaxin contains 800 mg of metaxalone and other inactive ingredients, such as ammonium calcium alginate, corn starch, magnesium stearate, alginic acid and B-rose liquid. The pills have pink colored and oval shape and oval form. It was approved by FDA in 1962.

Use

Skelaxin is used as a muscle relaxant. The drug acts by preventing the nerve impulses i.e. the pain feeling in the brain. It provides greater effect in combination with proper rest and physical therapy for the treatment of the skeletal muscle disorders, such as an injury or strong pain.
Skelaxin may also be used for the treatment of muscle cramps and different other health conditions.

Dosage

Take a pill of Skelaxin can 3-4 times a day orally, irrespective of the mealtime. However, it is better to take it without food or after a light snack so that the drug can start acting immediately.
If you take Skelaxin after a heavy meal, it may take the pill longer to start the action. Stick to the doctor’s prescriptions to avoid any possible adverse effects.
Different people may require various dosage of Skelaxin (depending on the patient’s age, health condition and reaction to the drug). Avoid taking the drug longer than necessary.

Adverse effects

The common side effects of this drug are vertigo, sleepiness, vomiting, indigestion, head pain and nausea.
Even though the benefit of this drug is greater than the risk of adverse effects, they still can appear in some patients.
Avoid drinking alcohol during the treatment with Skelaxin, as it may cause dangerous adverse effects and even be fatal.

Drug Interactions

The use of some medicines may cause drowsiness or breathing problems if taken with the other drugs. Avoid taking sleeping and narcotic drugs, other miorelaxants or antidepressants together with this muscle relaxant, as it can cause serious drug interactions.